Literature DB >> 26351621

Electroconvulsive Therapy in Multiple Sclerosis.

Katie Steen1, Puneet Narang1, Steven Lippmann1.   

Abstract

We performed a literature search regarding the safety and efficacy of electroconvulsive therapy in patients with multiple sclerosis and comorbid psychiatric symptoms. Literature review was conducted via PubMed databases. Of the cases we reviewed, most subjects with multiple sclerosis reported significant psychiatric symptom relief, with only a handful reporting neurologic deterioration. There was some evidence that active white matter lesions may be predictive of neurologic deterioration when electroconvulsive therapy is used in patients with multiple sclerosis. A brief description of the pathophysiology and effects of depression in patients with multiple sclerosis is also provided. Although no clinical recommendations or meaningful conclusions can be drawn without further investigation, the literature suggests that electroconvulsive therapy for treatment of psychiatric illnesses in patients with multiple sclerosis is safe and efficacious.

Entities:  

Keywords:  ECT; depression; electroconvulsive therapy; multiple sclerosis

Year:  2015        PMID: 26351621      PMCID: PMC4558788     

Source DB:  PubMed          Journal:  Innov Clin Neurosci        ISSN: 2158-8333


  15 in total

1.  Electroconvulsive therapy: evidence and challenges.

Authors:  Max Fink; Michael Alan Taylor
Journal:  JAMA       Date:  2007-07-18       Impact factor: 56.272

2.  Relationship between disease-modifying therapy and depression in multiple sclerosis.

Authors:  Stephen S Kirzinger; Jason Jones; Angela Siegwald; Andrew Bryce Crush
Journal:  Int J MS Care       Date:  2013

3.  Depressive symptoms and severity of illness in multiple sclerosis: epidemiologic study of a large community sample.

Authors:  Lydia Chwastiak; Dawn M Ehde; Laura E Gibbons; Mark Sullivan; James D Bowen; George H Kraft
Journal:  Am J Psychiatry       Date:  2002-11       Impact factor: 18.112

Review 4.  Suicide risk in multiple sclerosis: a systematic review of current literature.

Authors:  Maurizio Pompili; Alberto Forte; Mario Palermo; Henry Stefani; Dorian A Lamis; Gianluca Serafini; Mario Amore; Paolo Girardi
Journal:  J Psychosom Res       Date:  2012-10-12       Impact factor: 3.006

5.  Electroconvulsive therapy in a patient with multiple sclerosis and recurrent catatonia.

Authors:  Theodote K Pontikes; Stephen H Dinwiddie
Journal:  J ECT       Date:  2010-12       Impact factor: 3.635

6.  Multiple sclerosis and ECT: possible value of gadolinium-enhanced magnetic resonance scans for identifying high-risk patients.

Authors:  G Mattingly; K Baker; C F Zorumski; G S Figiel
Journal:  J Neuropsychiatry Clin Neurosci       Date:  1992       Impact factor: 2.198

7.  The risk of Bipolar Disorders in Multiple Sclerosis.

Authors:  M G Carta; M F Moro; L Lorefice; G Trincas; E Cocco; E Del Giudice; G Fenu; F Colom; M G Marrosu
Journal:  J Affect Disord       Date:  2013-11-19       Impact factor: 4.839

8.  Electroconvulsive therapy in patient with psychotic depression and multiple sclerosis.

Authors:  Małgorzata Urban-Kowalczyk; Tomasz Rudecki; Dariusz Wróblewski; Janusz Smigielski; Olga Kałużyńska; Jolanta Rabe-Jabłońska
Journal:  Neurocase       Date:  2013-05-16       Impact factor: 0.881

9.  Evidence-based guideline: assessment and management of psychiatric disorders in individuals with MS: report of the Guideline Development Subcommittee of the American Academy of Neurology.

Authors:  Sarah L Minden; Anthony Feinstein; Rosalind C Kalb; Deborah Miller; David C Mohr; Scott B Patten; Christopher Bever; Randolph B Schiffer; Gary S Gronseth; Pushpa Narayanaswami
Journal:  Neurology       Date:  2013-12-27       Impact factor: 9.910

10.  Depression and multiple sclerosis.

Authors:  A D Sadovnick; R A Remick; J Allen; E Swartz; I M Yee; K Eisen; R Farquhar; S A Hashimoto; J Hooge; L F Kastrukoff; W Morrison; J Nelson; J Oger; D W Paty
Journal:  Neurology       Date:  1996-03       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.